TY  - JOUR
AU  - Nath Basu, Narendra
AU  - Evans, D. Gareth
PY  - 2016
TI  - Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
JF  - Translational Cancer Research; Vol 5, Supplement 6 (November 30, 2016): Translational Cancer Research
Y2  - 2016
KW  - 
N2  - Women harbouring a deleterious mutation in the high penetrance BRCA1/2 genes have a lifetime risk of up to 85% of developing breast cancer (1). Once diagnosed, they have a significant risk of developing a contralateral breast cancer—approximately 2–3% per year. This risk persists for up to 30 years following an initial breast cancer diagnosis (2).
UR  - https://tcr.amegroups.org/article/view/10640